Home
About
FAQ
History (5)
Intrathecal delivery of nusinersen in individuals with complicated spines.
Managing uncommon and unexpected findings during neuromuscular ultrasound.
Pride and precision: Personalizing care in diagnostic neurology laboratories.
Selecting disease-modifying medications in 5q spinal muscular atrophy.
Ultrasonography in the intensive care setting can be used to detect changes in the quality and quantity of muscle and is related to muscle strength and function.
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Selecting disease-modifying medications in 5q spinal muscular atrophy.
Cartwright MS, Upadhya S. Selecting disease-modifying medications in 5q spinal muscular atrophy. Muscle Nerve. 2021 Oct; 64(4):404-412.
View in:
PubMed
subject areas
Animals
Azo Compounds
Biological Products
Humans
Muscular Atrophy, Spinal
Neuromuscular Agents
Oligonucleotides
Oligonucleotides, Antisense
Pyrimidines
Recombinant Fusion Proteins
Treatment Outcome
authors with profiles
Michael S. Cartwright MD